Global cancer cases are expected to rise dramatically, reaching 34 million annually by 2050, according to a new report led by the American Cancer Society (ACS) and the International Agency for Research on Cancer (IARC). This projection represents a 67% increase from current levels, driven by population growth and an aging global population. In 2024, nearly 21 million people worldwide were diagnosed with cancer, and 9.8 million people died from the disease. The study suggests that nearly one in five people will develop cancer in their lifetime, and almost half of all cancer-related deaths could be prevented through lifestyle changes, early detection, and effective treatment. The analysis is based on data from GLOBOCAN, a comprehensive database maintained by IARC that tracks cancer incidence and mortality across 34 cancer types in 186 countries. Researchers examined how cancer rates differ by region and the Human Development Index, which measures a country’s level of development. They then used demographic trends to project the global cancer burden in 2050. The findings highlight significant disparities in cancer incidence and mortality, with some regions experiencing much higher rates than others. Cancer incidence and mortality rates vary widely by region. Australia and New Zealand have the highest cancer rates, while parts of Africa and South-Central Asia have the lowest. Mortality rates are also uneven, with men in Eastern Europe and women in Melanesia facing the highest cancer death rates. Lung cancer remains the leading cause of both new cancer diagnoses and cancer deaths, with nearly 2.6 million new cases and 1.9 million deaths in 2024. Tobacco use is the primary cause of lung cancer, which is preventable through smoking cessation. Other major cancers include breast cancer, which is the second most common diagnosis globally, with 2.4 million new cases and 694,000 deaths. Women in Western Africa are twice as likely to die from breast cancer as those in Australia and New Zealand, despite lower incidence rates, indicating gaps in access to early detection and treatment. Colorectal cancer is the third most diagnosed and the second leading cause of cancer death, while liver cancer ranks third in mortality. Prostate cancer is the second most common in men and the fourth leading cause of cancer death, with particularly high mortality rates in the Caribbean and Sub-Saharan Africa. Cervical cancer, which is largely preventable through HPV vaccination and screening, remains a leading cause of death in many low-income countries.